The SWOG/Hope Foundation Impact Award funds innovative, early-stage cancer research leveraging SWOG resources or informing future SWOG/NCTN clinical trials.
Funder: Hope Foundation
Due Dates (Anticipated): January 2027: Letter of Intent deadline (projected, LOI due January 15 at 5pm ET)
Funding Amounts: Up to $250,000 total (direct + indirect, max 2 years); 25% IDC cap included.
Summary: Supports early-stage, high-impact cancer research projects leveraging SWOG resources or informing future SWOG/NCTN clinical trials.
The SWOG/Hope Foundation Impact Award is designed to accelerate innovative cancer research at its earliest and most conceptual stages. The program specifically funds projects that leverage resources from completed SWOG studies or are directly translatable to future clinical trials within SWOG or the National Clinical Trials Network (NCTN). Projects may involve scientific risk but should aim for significant impact, such as the development of novel techniques, agents, methodologies, models, or applications. The ultimate goal is to foster breakthroughs in cancer research and facilitate subsequent extramural funding and impactful publications.